Please assess the completion status of the following clinical trial:

Trial Title: Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Cohort Study:~* Weeks of pregnancy between 13 and 22 weeks~* Resident in Mbarara Municipality (radius of 15km from MNRH)~* Cohort study signed informed consent form~Efficacy Study:~* Pregnant woman~* Malaria infection, detected by microscopy, with P. falciparum (mixed or mono-infection)~* Age of gestation: 13 weeks and beyond~* Efficacy study signed informed consent form~Exclusion Criteria:~Efficacy Study:~* P. falciparum parasitaemia above 250,000 parasites/μl~* Severe anaemia~* Signs or symptoms of severe/complicated malaria requiring parenteral treatment (WHO 2000)~* Known allergy to artemisinin derivatives, lumefantrine or quinine;~* Previous participation in the efficacy study~* Inability to attend the efficacy study follow-up schedule.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Quinine (Type: ACTIVE_COMPARATOR): None
- Arthemeter lumefantrine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).